We are live on ! Find out more
JDR

Jay D. Rosenbaum Portfolio holdings

AUM $6.69M
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+4.68%
3 Year Est. Return
+12.92%
5 Year Est. Return
+74.65%
10 Year Est. Return
+173.05%
AUM
$60.3M
AUM Growth
+$2.02M
Cap. Flow
-$2.26M
Cap. Flow %
-3.74%
Top 10 Hldgs %
44.79%
Holding
46
New
1
Increased
8
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$993K
2
CVS icon
CVS Health
CVS
+$278K
3
NVS icon
Novartis
NVS
+$52.5K
4
NVDA icon
NVIDIA
NVDA
+$23.7K
5
MA icon
Mastercard
MA
+$20.4K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$785K
2
TIP icon
iShares TIPS Bond ETF
TIP
+$528K
3
AMGN icon
Amgen
AMGN
+$448K
4
INTC icon
Intel
INTC
+$398K
5
MSFT icon
Microsoft
MSFT
+$346K

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Financials 15.96%
3 Healthcare 15.17%
4 Communication Services 12.52%
5 Consumer Discretionary 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.94T
$6.15M 10.18%
22,687
-1,361
-6% -$346K
AAPL icon
2
Apple
AAPL
$5.04T
$4.17M 6.91%
30,463
-924
-3% -$120K
AMZN icon
3
Amazon
AMZN
$2.47T
$2.41M 3.99%
14,000
INTC icon
4
Intel
INTC
$425B
$2.31M 3.83%
41,138
-6,787
-14% -$398K
PG icon
5
Procter & Gamble
PG
$337B
$2.3M 3.82%
17,070
-1,050
-6% -$142K
SYK icon
6
Stryker
SYK
$135B
$2.24M 3.71%
8,608
-39
-0.5% -$9.97K
JPM icon
7
JPMorgan Chase
JPM
$929B
$2.14M 3.55%
13,781
-197
-1% -$30.9K
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.11T
$1.97M 3.26%
15,720
-160
-1% -$19.1K
TMO icon
9
Thermo Fisher Scientific
TMO
$213B
$1.73M 2.87%
3,432
-109
-3% -$51.4K
ROK icon
10
Rockwell Automation
ROK
$50.9B
$1.61M 2.66%
5,618
-33
-0.6% -$8.9K
TJX icon
11
TJX Companies
TJX
$180B
$1.59M 2.64%
23,658
+65
+0.3% +$4.43K
MDT icon
12
Medtronic
MDT
$113B
$1.57M 2.6%
12,660
-60
-0.5% -$7.53K
CMCSA icon
13
Comcast
CMCSA
$87.7B
$1.51M 2.51%
26,525
-245
-0.9% -$13.7K
CRM icon
14
Salesforce
CRM
$155B
$1.48M 2.45%
6,043
-20
-0.3% -$4.61K
PEP icon
15
PepsiCo
PEP
$197B
$1.41M 2.33%
9,500
-727
-7% -$106K
MA icon
16
Mastercard
MA
$500B
$1.4M 2.32%
3,838
+55
+1% +$20.4K
WM icon
17
Waste Management
WM
$95.8B
$1.26M 2.1%
9,028
-60
-0.7% -$8.29K
META icon
18
Meta Platforms (Facebook)
META
$1.51T
$1.24M 2.05%
3,553
-10
-0.3% -$3.21K
DIS icon
19
Walt Disney
DIS
$171B
$1.23M 2.04%
7,018
-20
-0.3% -$3.6K
BKNG icon
20
Booking.com
BKNG
$157B
$1.19M 1.98%
13,625
-100
-0.7% -$9.34K
LOW icon
21
Lowe's Companies
LOW
$122B
$1.18M 1.96%
6,095
-70
-1% -$13.7K
DHR icon
22
Danaher
DHR
$140B
$1.17M 1.93%
4,903
-576
-11% -$128K
ICE icon
23
Intercontinental Exchange
ICE
$87.4B
$1.14M 1.9%
9,634
+152
+2% +$17.5K
BAC icon
24
Bank of America
BAC
$435B
$1.14M 1.89%
27,640
-150
-0.5% -$6.15K
VZ icon
25
Verizon
VZ
$201B
$1.09M 1.81%
19,545
-15
-0.1% -$861

Similar funds

Jay D. Rosenbaum's Q2 2021 Portfolio in Review

As of Q2 2021, Jay D. Rosenbaum held 46 positions worth $60.3M, up 3.5% from $58.3M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Jay D. Rosenbaum withdrew a net $2.26M in Q2 2021, closing 4 positions and reducing 29 holdings. Its most notable exit was T. Rowe Price, an estimated $785K position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jay D. Rosenbaum opened a new position in Blackrock worth $1.03M.

  • Jay D. Rosenbaum's largest Q2 2021 buy was Blackrock: 1,176 shares worth $1.03M.
  • Jay D. Rosenbaum added most to CVS Health in Q2 2021, an estimated $278K increase.
  • Jay D. Rosenbaum's biggest Q2 2021 reduction was Intel, cutting an estimated $398K.
  • Jay D. Rosenbaum fully exited T. Rowe Price in Q2 2021, selling an estimated $785K.
  • Jay D. Rosenbaum's ten largest holdings make up 45% of its $60.3M portfolio in Q2 2021.
  • Jay D. Rosenbaum opened 1 new position and closed 4 in Q2 2021.
  • Jay D. Rosenbaum's portfolio value rose 3.5% quarter-over-quarter to $60.3M.

Based on Jay D. Rosenbaum's 13F filing for Q2 2021, filed 14 Jul 2021.